Simultaneous FAPI PET/MRI Targeting the Fibroblast-Activation Protein for Breast Cancer
Top Cited Papers
- 1 January 2022
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 302 (1) , 39-47
Abstract
Simultaneous gallium 68 (68Ga) fibroblast-activation protein (FAP) inhibitor–46 breast PET/MRI followed by whole-body scanning targeting the FAP showed excellent imaging characteristics and added d... Background Integrated PET/MRI is a promising modality for breast assessment. The most frequently used tracer, fluorine 18 (18F) fluorodeoxyglucose (FDG), is applied for whole-body staging in advanc...Keywords
Funding Information
- Ninth Deutsche Forschungsgemeinschaft (project B06)
This publication has 23 references indexed in Scilit:
- Dedicated Breast Gamma Camera Imaging and Breast PETPET Clinics, 2018
- Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinJournal of Nuclear Medicine, 2018
- A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsJournal of Nuclear Medicine, 2018
- Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancerHuman Pathology, 2013
- FDG PET-CT in Non-small Cell Lung Cancer: Relationship between Primary Tumor FDG Uptake and Extensional or Metastatic PotentialAsian Pacific Journal of Cancer Prevention, 2013
- Performance of FDG PET/CT in the Clinical Management of Breast CancerRadiology, 2013
- Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinomaDiagnostic Pathology, 2011
- Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysisEuropean Radiology, 2011
- Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II–III breast cancerEuropean Journal of Cancer, 2010